Koers GINO BIOW Nasdaq
Aandelen
DNA
US37611X1000
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 223 mln. 209 mln. | Omzet 2025 * | 310 mln. 290 mln. | Marktkapitalisatie | 1,72 mld. 1,61 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -631 mln. -590 mln. | Nettowinst (verlies) 2025 * | -534 mln. -499 mln. | EV/omzet 2024 * | 4,68 x |
Nettoliquiditeiten 2024 * | 676 mln. 632 mln. | Nettoliquiditeiten 2025 * | 550 mln. 514 mln. | EV/omzet 2025 * | 3,78 x |
K/w-verhouding 2024 * |
-2,69
x | K/w-verhouding 2025 * |
-3,17
x | Werknemers | 1.218 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 66,98% |
Recentste transcriptie over GINO BIOW
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Austin Che
FOU | Founder | - | 01-01-08 |
Founder | - | 01-01-08 | |
Reshma Shetty
FOU | Founder | 43 | 01-01-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 16-09-21 |
Marijn Dekkers
CHM | Chairman | 65 | 16-09-21 |
Kathy Hannan
BRD | Director/Board Member | 62 | 02-08-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |